Ragan Hart

1.9k total citations
7 papers, 138 citations indexed

About

Ragan Hart is a scholar working on Genetics, Economics and Econometrics and Pathology and Forensic Medicine. According to data from OpenAlex, Ragan Hart has authored 7 papers receiving a total of 138 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 2 papers in Economics and Econometrics and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Ragan Hart's work include Genomics and Rare Diseases (4 papers), BRCA gene mutations in cancer (4 papers) and Pharmaceutical Economics and Policy (2 papers). Ragan Hart is often cited by papers focused on Genomics and Rare Diseases (4 papers), BRCA gene mutations in cancer (4 papers) and Pharmaceutical Economics and Policy (2 papers). Ragan Hart collaborates with scholars based in United States, South Africa and Canada. Ragan Hart's co-authors include Laura M. Amendola, David L. Veenstra, Gail P. Jarvik, Kelly M. East, Sawona Biswas, Julia Wynn, Marian J. Gilmore, Sarah Scollon, Joshua A. Roth and Denise M. Boudreau and has published in prestigious journals such as The American Journal of Medicine, Value in Health and Journal of Genetic Counseling.

In The Last Decade

Ragan Hart

7 papers receiving 136 citations

Peers

Ragan Hart
Kate Krempely United States
Gemma R. Brett Australia
Jessie H. Conta United States
Cara Z. McCormick United States
Emma Perez United States
Adam M Lee United States
Sylvia Mann Au United States
Kate Krempely United States
Ragan Hart
Citations per year, relative to Ragan Hart Ragan Hart (= 1×) peers Kate Krempely

Countries citing papers authored by Ragan Hart

Since Specialization
Citations

This map shows the geographic impact of Ragan Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ragan Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ragan Hart more than expected).

Fields of papers citing papers by Ragan Hart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ragan Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ragan Hart. The network helps show where Ragan Hart may publish in the future.

Co-authorship network of co-authors of Ragan Hart

This figure shows the co-authorship network connecting the top 25 collaborators of Ragan Hart. A scholar is included among the top collaborators of Ragan Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ragan Hart. Ragan Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hart, Ragan & Scott Spencer. (2019). Consideration for Employer-Based and Geographic Attributes Included in Value Assessment Methods of Next-Generation Sequencing Tests. Journal of Managed Care & Specialty Pharmacy. 25(8). 936–940. 2 indexed citations
2.
Amendola, Laura M., Ragan Hart, Robin L. Bennett, et al.. (2019). Insurance coverage does not predict outcomes of genetic testing: The search for meaning in payer decisions for germline cancer tests. Journal of Genetic Counseling. 28(6). 1208–1213. 13 indexed citations
3.
Hart, Ragan, Louis P. Garrison, Debra Lochner Doyle, et al.. (2019). Projected Cost-Effectiveness for 2 Gene-Drug Pairs Using a Multigene Panel for Patients Undergoing Percutaneous Coronary Intervention. Value in Health. 22(11). 1231–1239. 13 indexed citations
4.
Li, Meng, Caroline S. Bennette, Laura M. Amendola, et al.. (2018). The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation. Journal of Genetic Counseling. 28(2). 477–490. 38 indexed citations
5.
Amendola, Laura M., Jill O. Robinson, Ragan Hart, et al.. (2018). Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium. Journal of Genetic Counseling. 27(5). 1220–1227. 30 indexed citations
6.
Hart, Ragan, David L. Veenstra, Denise M. Boudreau, & Joshua A. Roth. (2016). Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting. The American Journal of Medicine. 130(2). 222–228. 16 indexed citations
7.
Amendola, Laura M., Denise Lautenbach, Sarah Scollon, et al.. (2015). Illustrative Case Studies in the Return of Exome and Genome Sequencing Results. Personalized Medicine. 12(3). 283–295. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026